The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Workforce
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Study Sees Improvement in OA Patients Who Received Ayurvedic Therapy

Study Sees Improvement in OA Patients Who Received Ayurvedic Therapy

October 18, 2018 • By Elizabeth Hofheinz, MPH, MEd

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Africa Studio / shutterstock.com

Africa Studio / shutterstock.com

Mounting evidence suggests that humans have a complex and integrated mind-body system. Knee problems may affect the spine and other body parts, but also the mind—and vice versa. This is the wisdom of Ayurveda, the 3,000-year-old traditional medicine from India.

You Might Also Like
  • MRI-Guided Therapy Offers No Improvement Over Conventional Treat to Target for RA
  • Study Points to Need for Increased Antirheumatic Therapy in Patients with Dyslipidemia
  • Participate in CMS Reporting Study to Receive 2018 Improvement Activity Credit
Explore This Issue
October 2018
Also By This Author
  • Study Finds Young Adults with Lupus at High Risk for Depression

A team of researchers from Germany recently undertook a study, titled “Effectiveness of an Ayurveda treatment approach in knee osteo­arthritis—a randomized controlled trial,1” which appears in the May 2018 edition of Osteoarthritis and Cartilage.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Christian S. Kessler, MD, works in the Department for Complementary and Integrative Medicine at Charité University & Immanuel Hospital in Berlin, Germany. Along with colleagues from multiple countries, Dr. Kessler delved into the issue of how Ayurveda, widely used in India for a variety of ailments, is able to move the needle on the pain of osteoarthritis (OA).

He says, “Our institute is one of Europe’s largest facilities for the study and practice of complementary medical research. While I have been interested in traditional Indian medicine—Ayurveda—for over 20 years, it is only lately that clinical research on this multimodal practice is on the rise in the West. Given the need for concrete data according to the principles of evidence-based medicine, we thought it would be wise to undertake a randomized controlled trial.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Why OA?

“Knee OA has a high economic burden and prevalence in Western countries and worldwide,” Dr. Kessler notes. “We took care to undertake a well-designed study that was adapted to the specifics of Ayurveda. Plus, in the case of OA, there is a substantial overlap between the Western diagnosis of OA and the diagnostic entity in Ayurveda known as sandhi-gata-vata. Ayurveda is not only nutrition and lifestyle, but an entire sophisticated medical system that makes use of a multimodal approach to individualize treatment according to Ayurvedic principles. While there has been previous clinical research purporting to address Ayurveda, almost all of these trials actually left out certain elements of Ayurveda therapy. This is our attempt to rectify that.”

In what was the first randomized controlled confirmatory study on the use of multimodal Ayurveda to treat knee OA, researchers enrolled 151 individuals (77 in the Ayurveda group and 74 in the conventional care group). Participants in the conventional group received multimodal and individualized conventional care for knee OA according to current guidelines. This included quadriceps muscle-strengthening exercises; knee-specific physiotherapy, including manual therapy; occupational therapy; advice for home knee exercises; dietary advice for weight loss for overweight participants; and, if necessary, administration of long-term pain medication according to current guidelines. The study, a head-to-head comparison between Ayurveda and conventional guideline-based OA treatment, did not include a placebo or a sham intervention.

Pages: 1 2 3 | Single Page

Filed Under: Conditions, Osteoarthritis Tagged With: Ayurveda, Ayurvedic therapy, Ayurvedic treatment, mind-body therapyIssue: October 2018

You Might Also Like:
  • MRI-Guided Therapy Offers No Improvement Over Conventional Treat to Target for RA
  • Study Points to Need for Increased Antirheumatic Therapy in Patients with Dyslipidemia
  • Participate in CMS Reporting Study to Receive 2018 Improvement Activity Credit
  • Antiplatelet Therapy May Protect Renal Function in Some Lupus Patients

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.